Clinical Scorecard: Integrase Inhibitor Antiretroviral Therapy Promotes Changes in Gut Microbiota and Enhances Immune Function in HIV Patients
At a Glance
Category
Detail
Condition
Key Mechanisms
Integrase strand transfer inhibitors (INSTIs) promote gut microbiota restoration, enhance immune function, and reduce systemic inflammation.
Target Population
Care Setting
Key Highlights
Higher CD4+ T cell counts correlate with increased abundance of short-chain fatty acid producers, indicating improved gut health.
Guideline-Based Recommendations
Diagnosis
Management
Monitoring & Follow-up
Regular assessment of gut microbiota composition using 16S rRNA sequencing and immune function metrics in patients on ART.
Risks
Patient & Prescribing Data
INSTI-based ART may enhance gut microbiota and immune function, but monitor for potential side effects and consider adjunctive therapies like probiotics.
Clinical Best Practices
Encourage dietary modulation to support gut health in HIV patients, referencing studies on specific dietary impacts.
